Expanded biobanks, education, and genomics research investments - Saudi Arabia transforming healthcare

Continue Reading

Oxford Nanopore Technologies and Saphetor announce a new partnership to deliver tertiary analysis for comprehensive interpretation of nanopore sequencing

Continue Reading

CING studies ABT with the help of VarSome Clinical

Continue Reading

Building the best in variant classification

Continue Reading

Saphetor SA receives IVDR Certification for clinical diagnosis support NGS data analysis platform, VarSome Clinical, ensuring enhanced safety and performance standards

Continue Reading

Gene fusion detection: Liquid biopsies and classification of co-mutations

Continue Reading

Expanded biobanks, education, and genomics research investments - Saudi Arabia transforming healthcare

Continue Reading

Company News listing page

By

Categories

Stay up to date

Topic: News

Lausanne, Switzerland - September 15, 2022 - Saphetor SA, a Switzerland-based precision medicine company recognized for its industry leading variant interpretation platform VarSome, has been successfully selected as one of the twelve companies to...

Press Releases Partnerships News

Instand-NGS4P tender selects Saphetor's VarSome
By Carl Smith on September 15, 2022
0
Continue Reading

Lausanne, Switzerland, July 12, 2022 - Saphetor, a global precision medicine company and the creator of VarSome, The Human Genomics Community and variant interpretation platform, announced today a partnership with PTC Therapeutics International...

Press Releases News

Saphetor Partners with PTC Therapeutics to advance awareness of clinical programs in rare diseases
By Carl Smith on July 12, 2022
0
Continue Reading

Saphetor was featured in Nature Portfolio's Biopharma Dealmakers this week. The article explains how and why Saphetor developed VarSome. You can read the full article here.

Press Releases News

Saphetor in Nature Portfolio's Biopharma Dealmakers
By Carl Smith on April 13, 2022
0
Continue Reading

Partnerships VarSome Clinical News

Gencell Pharma S.A.S. to adopt VarSome Clinical for high-throughput analysis of clinical exomes and genomes sequenced on MGI DNBSEQ-G400 and T7 platforms
By Carl Smith on March 29, 2022
0
Continue Reading

VarSome is sponsoring this year'sAmerican Society of Human Genetics Virtual Annual Meeting, October 18-22.

Events News

VarSome at ASHG 2021
By Carl Smith on October 19, 2021
0
Continue Reading

Saphetor was featured in a Forbes article this week, highlighting the companies doing great work in the UK genomics ecosystem. The article covers our founder and CEO, Andreas Massouras, VarSome, and the incredible growth of the company through smart...

News

Saphetor in Forbes
By Carl Smith on September 3, 2021
1
Continue Reading

Submit a Comment

Stay up to date